Here, the TAT-Kα2 peptide showed no cytotoxicity or CPE at concentrations up to 100 μM, and the peptide elicited a significant anti-influenza effect at very low dose, producing over 95% of inhibition at 2 μM (Fig. S5). The gene discussed is GRIK5; the disease is influenza.